Chad Watkins
General Manager, Isotope Strategy Telix Pharmaceuticals
Seminars
Wednesday 22nd July 2026
Securing a Supply of Isotopes Within a Radioisotope Agnostic Portfolio
12:00 pm
- Advancing next-generation isotopes and their potential to transform targeted radioligand therapy
- Strengthening global production and partnership networks to ensure reliable, scalable supply
- Addressing the challenges of introducing a novel isotope in the absence of extensive clinical data while maintaining supply chain integrity
Wednesday 22nd July 2026
Advancing Actinium: Perspectives on Quality, Supply, and Commercial Readiness
1:30 pm
- Establishing a target product profile for new isotopes, navigating isotope purity based on its method of production, and understanding the impact of isotope specifications on drug product quality attributes.
- Supply, Logistics and Manufacturing: Evaluating supply chain robustness, coordinating global logistics, and managing the proximity of isotope and drug product manufacture
- Life-Cycle Management and Regulatory Support: Managing isotope life-cycle across the drug product development continuum and navigating the regulatory requirements to enable broad material utilization.
